Read + Share
Garrido-Castro AC, Saura C, Barroso-Sousa R, Guo H, et al. Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients
with metastatic triple-negative breast cancer. Breast Cancer Res 2020;22:120.
PMID: 33138866
|
 |
|
Garrido-Castro AC, Saura C, Barroso-Sousa R, Guo H, et al. Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients
with metastatic triple-negative breast cancer. Breast Cancer Res 2020;22:120.
PMID: 33138866
|
|
|
|